AASLD

10/23/2026

Co-Editors-in-Chief Elliot B. Tapper, MD, FAASLD, and Carmen Chak-Lui Wong, PhD, share highlights from the October issue of , featuring major multicenter studies on hepatic decompensation, acute kidney injury in alcohol-associated hepatitis, liver fibrosis screening in high-risk populations, pediatric primary sclerosing cholangitis, and alcohol-use trajectories in adolescents with MASLD.

Additional highlights include new insights into proinflammatory monocytes, ferroptosis in liver disease, and prime editing in liver organoids to predict treatment response to resmetirom!

Watch the video and explore the latest issue: https://journals.lww.com/hepcomm/toc/current

Co-Editors-in-Chief Elliot B. Tapper and Carmen Chak-Lui Wong highl...

10/23/2026

The countdown is on! ⏳ In less than a few weeks, the hepatology community unites for 5 days of game-changing research, fresh clinical perspectives, and in-person connections that spark real progress in liver care.

Stay tuned for updates and announcements as we gear up for kickoff. 🎉

10/22/2026

The new guideline on primary biliary cholangitis is now live!

Attending ? Join us for two expert-led sessions exploring key updates and practical applications in clinical care:

🔹 Nov. 6: From Evidence to Practice https://bit.ly/4zEf62g

🔹 Nov. 7: Inside the Journals: AASLD AGA Guideline on Management of PBC https://bit.ly/3WFlvvU

💡 Most people living with primary biliary cholangitis (PBC) are cared for by general GIs, making it important for the broader GI community to have access to the latest evidence and treatment options.

Our new joint guideline with AASLD helps clinicians navigate a changing PBC treatment landscape, from diagnosing challenging cases to deciding when to move beyond first-line therapy and when to consider a novel treatment for pruritus.

🔗 Explore the recommendations: https://ow.ly/TENl50ZZIG3

10/21/2026

Continue your support during by getting back to the fundamentals of liver cancer. Explore this course of short video interviews covering hepatocellular carcinoma (HCC) topics. Register now at https://bit.ly/4g0zNyM.

10/20/2026

From education and new insights to conversations with colleagues and connections across the hepatology community, here’s just a glimpse of what could be on your agenda at .

What will your days at TLM look like? 👀

10/19/2026

🔥 HOT TOPIC

📙

How have liver transplant trends for PBC and PSC changed over the past two decades?

Drawing on two major registries and more than 22,000 recipients across the U.S. and Europe, this study reveals divergent transplant trends, long-term outcomes and predictors of mortality—highlighting both advances and persistent unmet needs in cholestatic liver disease.

Read the article: https://bit.ly/4dqn4Uc

10/17/2026

Keep the latest liver research in your feed. 🔬

Follow the AASLD Publications Showcase on LinkedIn for monthly highlights from , , and , featuring noteworthy studies, emerging insights, and research advancing liver disease care.

📲 Stay connected to the research shaping the future of hepatology: https://bit.ly/44Qh0jj

10/16/2026

🏅 Turn your contributions into recognition.

Your work is helping advance . Take the next step by applying for Fellow of the AASLD (FAASLD) or Associate Fellow of the AASLD recognition.

Join a distinguished community of professionals recognized for their contributions to research and care.

🔗 Learn more and apply by Tuesday, Dec. 15: https://bit.ly/3DafgH0.

10/16/2026

The CDC’s Division of Viral Hepatitis has released its 2030 Strategic Plan, outlining key priorities to prevent new infections, reduce viral hepatitis-related illness and deaths, address health disparities, and strengthen public health surveillance.

AASLD applauds this important step forward and remains committed to supporting efforts to expand testing, vaccination, treatment, and access to care.

Continued investment and collaboration are essential to advancing our shared goal of eliminating viral hepatitis.

🔗 Learn more at the AASLD Policy Communications webpage: https://www.aasld.org/policy-communications

10/15/2026

🆕 Introducing AASLD EXPOs!

AASLD has published its first-ever Expert-Based Practice Opinion , launching a new type of clinical resource designed to deliver timely, expert-informed recommendations in areas of hepatology where evidence is limited, emerging, or rapidly evolving.

Published in , the inaugural AASLD EXPO on addresses the contemporary role of liver biopsy, including patient selection, biopsy technique, safety and monitoring, specimen adequacy and pediatric considerations.

This first EXPO reflects an evolving landscape in liver disease care, including advances in noninvasive assessment and endoscopic ultrasound-guided liver biopsy (EUS-LB).

🔗 Read the first AASLD EXPO: https://bit.ly/4dH2I9l